PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
25-Sep-2025 ACT appointed for POLB 001 Phase 2a Trial and supply of approved bispecific antibody drug secured at no cost Poolberg Pharma
24-Sep-2025 Microbiotica Announces Completion of Recruitment in its International Phase 1b Trial (MELODY-1) of MB097, a Precision Microbiome Co-Therapy in Advanced Melanoma Being Tested in Combination with MSD’s anti-PD-1 Therapy, KEYTRUDA® (pembrolizumab) Microbiotica
24-Sep-2025 Cambridge Network launches Graduate Scheme to develop future leaders Cambridge Network
24-Sep-2025 Proscia to Expand Pathology AI Capabilities with Virtual Staining Proscia
24-Sep-2025 Sonomind secures €3 million to advance its novel neuromodulation ultrasound device and opens a new therapeutic pathway in psychiatry and neurology Andrew Lloyd Associates
24-Sep-2025 Sapio Sciences Appoints Rich Roda as Chief Financial Officer Sapio Sciences
24-Sep-2025 Sanofi commits an additional $625 million to Sanofi Ventures to accelerate investment in biotech and digital health innovation Sanofi
24-Sep-2025 Xeltis poised for commercialization following excellent clinical data from aXess EU pivotal multicentre trial Xeltis
23-Sep-2025 Epitopea Strengthens Scientific Advisory Board with Appointment of Four World Renowned Experts in Cancer Immunology and Immunotherapy Epitopea
23-Sep-2025 UCB announces successful first-in-patient trial for galvokimig in moderate-to-severe atopic dermatitis at EADV UCB
23-Sep-2025 Sanofi launches Real Skinformation, an AI-powered website supporting healthcare professionals in tackling online skincare trends and misinformation Sanofi
23-Sep-2025 eXmoor Pharma and Siam Bioscience form strategic partnership to establish leading Cell and Gene Therapy services in Southeast Asia eXmoor Pharma
23-Sep-2025 Sanofi and Regeneron’s Dupixent to treat chronic spontaneous urticaria advances in EU with positive CHMP opinion Sanofi, Regeneron
23-Sep-2025 Abu Dhabi Biobank expands access to cord blood banking services with major NMC Healthcare partnership Abu Dhabi Biobank
23-Sep-2025 C4X Discovery announces selection of a once-daily development candidate from its α4β7 inhibitor programme C4X Discovery
23-Sep-2025 EMV Capital acquires antibiotic assets from Destiny Pharma EMV Capital, Destiny Pharma
23-Sep-2025 ADC Innovator Myricx Bio Appoints Boston-based Mohit Rawat as CEO and Expands Team in US and UK Myricx Bio
23-Sep-2025 BetaGlue Therapeutics Announces the Appointment of Alexis Peyroles as New Chief Executive Officer BetaGlue Therapeutics
23-Sep-2025 Servier receives approval from European Commission for Voranigo® (vorasidenib), first targeted therapy for Patients with Grade 2 IDH-mutant Glioma Servier
23-Sep-2025 Bristol Myers Squibb plans to launch Cobenfy (xanomeline and trospium chloride) in the UK at a list price equal to the US list price Bristol Myers Squibb